Eiger Biopharmaceuticals (EIGR)
NASDAQ:EIGR
Holding EIGR?
Track your performance easily

Eiger Biopharmaceuticals (EIGR) Cash flow

592 Followers

Eiger Biopharmaceuticals Cash Flow

EIGR's free cash flow for Q4 2023 was $-13.95M. For the 2023 fiscal year, EIGR's free cash flow was decreased by $8.57M and operating cash flow was $-13.95M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -74.55M$ -74.55M$ -83.01M$ -71.34M$ -63.19M$ -63.61M
Investing Cash Flow
$ 74.23M$ 74.23M$ 9.63M$ 61.53M$ -44.79M$ -16.47M
Financing Cash Flow
$ 41.00K$ 41.00K$ 76.95M$ 3.17M$ 97.46M$ 58.20M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 119.14M$ 25.44M$ 25.80M$ 22.22M$ 28.86M$ 39.37M
Income Tax Paid Supplemental Data
$ 269.00K$ 269.00K$ 64.00K---
Interest Paid Supplemental Data
$ 3.97M$ 3.97M$ 2.88M$ 2.78M$ 2.79M$ 2.64M
Issuance Of Capital Stock
$ 56.00K$ 56.00K$ 71.40M$ 3.30M$ 96.78M$ 53.19M
Issuance Of Debt
--$ 5.45M-$ 0.00$ 6.63M
Repayment Of Debt
--$ -34.39M-$ 0.00$ -1.67M
Free Cash Flow
$ -60.22M$ -74.78M$ -83.35M$ -71.57M$ -63.44M$ -64.09M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Eiger Biopharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis